TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34228099

Group type: EXPERIMENTAL
Intervention: Immunoguided strategy (prophylaxis until CMV-CMI recovery)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Fixed-duration prophylaxis (until day 90)
Number of subjects: 150
Study: 33469090

Group type: EXPERIMENTAL
Intervention: Silicon (2.5 mM) added to nutrient solution
Number of subjects: 5

Group type: COMPARATOR
Intervention: Calcium sufficiency (5 mM) without silicon
Number of subjects: 5
Study: 32790453

Group type: EXPERIMENTAL
Intervention: Internet-based intervention (IBI) for psychosis
Number of subjects: 101

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 101
Study: 35292837

Group type: EXPERIMENTAL
Intervention: ViVi® SSHS with HFD Hood (saccharin cohort)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (placebo cohort)
Number of subjects: 40
Study: 36125020

Group type: EXPERIMENTAL
Intervention: Laser guidance on mini C-arm
Number of subjects: 25

Group type: COMPARATOR
Intervention: No laser guidance on mini C-arm
Number of subjects: 25
Study: 33526397

Group type: EXPERIMENTAL
Intervention: Topical Vancomycin Powder and Dilute Povidone-Iodine (VIP) protocol
Number of subjects: 18299

Group type: COMPARATOR
Intervention: Control group (pre-VIP protocol)
Number of subjects: 18299
Study: 32240909

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (SCRT) followed by chemotherapy (6 cycles CAPOX or 9 cycles FOLFOX4)
Number of subjects: 901

Group type: COMPARATOR
Intervention: Long-course radiotherapy (25-28 × 2-1.8 Gy) with concomitant capecitabine followed by surgery and optional postoperative chemotherapy (8 cycles CAPOX or 12 cycles FOLFOX4)
Number of subjects: 901
Study: 36190481

Group type: COMPARATOR
Intervention: 20,000 IU/10 d (standard dose)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 60,000 IU/10 d (high dose)
Number of subjects: 82
Study: 32267568

Group type: EXPERIMENTAL
Intervention: Repeat forward-view (RF) examination of the right-sided colon
Number of subjects: 640

Group type: COMPARATOR
Intervention: Standard forward-view (SF) examination of the right-sided colon
Number of subjects: 640
Study: 35631145

Group type: EXPERIMENTAL
Intervention: Vitadio (digital program)
Number of subjects: 100

Group type: COMPARATOR
Intervention: In-person consultations (control group)
Number of subjects: 100
Study: 34087194

Group type: EXPERIMENTAL
Intervention: Street view greenness (IQR = 3.6%)
Number of subjects: 24845

Group type: EXPERIMENTAL
Intervention: Street view greenness
Number of subjects: 24845
Study: 32040341

Group type: EXPERIMENTAL
Intervention: Five-gene signature (including one long noncoding RNA and four protein-coding genes)
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Five-gene signature
Number of subjects: 757
Study: 35214798

Group type: COMPARATOR
Intervention: ShigETEC vaccine (5 × 10^10 colony forming units)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ShigETEC vaccine
Number of subjects: 0
Study: 34562773

Group type: EXPERIMENTAL
Intervention: Cognitive attitude plus positive affect message
Number of subjects: 484

Group type: COMPARATOR
Intervention: Control condition (no message)
Number of subjects: 484
Study: 35221255

Group type: EXPERIMENTAL
Intervention: Right ventricular septal pacing
Number of subjects: 141

Group type: COMPARATOR
Intervention: Right ventricular apical pacing
Number of subjects: 141
Study: 33081606

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100 µg/25 µg
Number of subjects: 283

Group type: COMPARATOR
Intervention: Vilanterol (VI) 25 µg
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 283
Study: 35584932

Group type: EXPERIMENTAL
Intervention: Prasugrel single antiplatelet therapy (SAPT) after short-term dual antiplatelet therapy (DAPT)
Number of subjects: 1107

Group type: COMPARATOR
Intervention: Long-term dual antiplatelet therapy (DAPT)
Number of subjects: 1107
Study: 32047100

Group type: EXPERIMENTAL
Intervention: Conversations with a doctor about HIV testing
Number of subjects: 699

Group type: COMPARATOR
Intervention: No conversations with a doctor about HIV testing
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Age groups
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Sexual experience
Number of subjects: 699
Study: 33526434

Group type: EXPERIMENTAL
Intervention: telephone cognitive-behavioural therapy (tCBT)
Number of subjects: 996

Group type: COMPARATOR
Intervention: usual care (UC)
Number of subjects: 996
Study: 32040141

Group type: EXPERIMENTAL
Intervention: Outpatient integrated palliative care (PC) administered by a neurologist, social worker, chaplain, and nurse.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard care alone.
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Outpatient integrated palliative care (PC) at 12 months.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard care alone at 12 months.
Number of subjects: 210
Study: 34437944

Group type: EXPERIMENTAL
Intervention: Guided Femoroplasty (automated radiographic visualization tool)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Routine fluoroscopy (Control)
Number of subjects: 28
Study: 36102287

Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study: 34151672

Group type: COMPARATOR
Intervention: Plain Balloon Angioplasty (POBA)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Drug Coated Balloon (DCB) (Paclitaxel)
Number of subjects: 301
Study: 32928798

Group type: EXPERIMENTAL
Intervention: Adherence to individual practices (WHO Safe Childbirth Checklist)
Number of subjects: 3274

Group type: EXPERIMENTAL
Intervention: Direct provider care practices
Number of subjects: 3274

Group type: EXPERIMENTAL
Intervention: Overall adherence to practices
Number of subjects: 3274
Study: 35778318

Group type: COMPARATOR
Intervention: Generic prevention materials
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: Precision prevention materials (average genetic risk)
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: Precision prevention materials (higher genetic risk)
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: Spanish language materials
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: English language materials (precision prevention groups)
Number of subjects: 920
Study: 33544653

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise training (45‐55% heart rate reserve)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Vigorous intensity exercise training (70‐85% heart rate reserve)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 35927504

Group type: EXPERIMENTAL
Intervention: Selected multistrain probiotics (N = 28) for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (N = 32) for 12 weeks
Number of subjects: 60
Study: 36102219

Group type: EXPERIMENTAL
Intervention: Maternal metabolic parameters (fasting glucose, insulin, HOMA-IR, leptin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low glycaemic index diet (as part of the ROLO study)
Number of subjects: 0
Study: 34165599

Group type: EXPERIMENTAL
Intervention: Rapid Ventricular Pacing (RP)
Number of subjects: 473

Group type: COMPARATOR
Intervention: Fast Ventricular Pacing (FP)
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Protective criteria (0-2 criteria)
Number of subjects: 473
Study: 32770131

Group type: EXPERIMENTAL
Intervention: Tap water from public drinking fountains
Number of subjects: 0

Group type: COMPARATOR
Intervention: Filtered water from point-of-use (POU) water dispensers
Number of subjects: 0
Study: 35355333

Group type: EXPERIMENTAL
Intervention: Attention-control training
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo attention training
Number of subjects: 59
Study: 34676743

Group type: EXPERIMENTAL
Intervention: Two-handed jaw thrust technique
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional i-gel insertion
Number of subjects: 74
Study: 32609011

Group type: EXPERIMENTAL
Intervention: Angiotensin II therapy
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study: 35239968

Group type: EXPERIMENTAL
Intervention: Ustekinumab q12w
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Ustekinumab q8w
Number of subjects: 348

Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 348
Study: 33292873

Group type: EXPERIMENTAL
Intervention: Yoga training (YT)
Number of subjects: 348
Study: 34453530

Group type: EXPERIMENTAL
Intervention: Explanation about a hypothetical transition to a biosimilar with companion
Number of subjects: 79

Group type: COMPARATOR
Intervention: Explanation about a hypothetical transition to a biosimilar alone
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Emotional support from companions
Number of subjects: 79
Study: 34147116

Group type: EXPERIMENTAL
Intervention: Caffeinated chewing gum (5.4 mg/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Caffeinated chewing gum (2.7 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Non-caffeinated chewing gum
Number of subjects: 9
Study: 36313781

Group type: EXPERIMENTAL
Intervention: Radiomics model based on CT imaging features of paravertebral muscles
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Combined Nomogram model based on radiomics and clinical characteristics
Number of subjects: 149

Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 149
Study: 32882693

Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises
Number of subjects: 97

Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 97
Study: 33355217

Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir (LPV/r)
Number of subjects: 19
Study: 34152561

Group type: EXPERIMENTAL
Intervention: CVD group (n=108)
Number of subjects: 1826

Group type: COMPARATOR
Intervention: Non-CVD group (n=1718)
Number of subjects: 1826

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1826
Study: 33032471

Group type: EXPERIMENTAL
Intervention: Bifidobacterium infantis NLS super strain (B. infantis NLS‐SS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 35589595

Group type: EXPERIMENTAL
Intervention: Indobufen combined with clopidogrel
Number of subjects: 152

Group type: COMPARATOR
Intervention: Aspirin combined with clopidogrel
Number of subjects: 152
Study: 33620407

Group type: EXPERIMENTAL
Intervention: Baclofen (50 to 150 mg per day)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 314
Study: 34031109

Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) diagnosis
Number of subjects: 847

Group type: COMPARATOR
Intervention: Integrated Management of Childhood Diseases implementation
Number of subjects: 847
Study: 34269688

Group type: EXPERIMENTAL
Intervention: Digital intervention (ADvisor HP)
Number of subjects: 19
Study: 32611648

Group type: EXPERIMENTAL
Intervention: Adavosertib (225 mg twice daily for 2.5 days/21-day cycle) plus carboplatin (AUC5) and paclitaxel (175 mg/m2)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo plus carboplatin (AUC5) and paclitaxel (175 mg/m2)
Number of subjects: 121
Study: 33559338

Group type: EXPERIMENTAL
Intervention: Smartphone application (app) to monitor longitudinal electronic patient‐reported outcomes (ePROs)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Care coordination with smartphone app
Number of subjects: 191

Group type: COMPARATOR
Intervention: Care coordination alone (control)
Number of subjects: 191
Study: 32271919

Group type: EXPERIMENTAL
Intervention: Rice
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Chickpeas
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Chickpeas plus rice (mixed meal)
Number of subjects: 11

Group type: COMPARATOR
Intervention: l‐methionine (reference diet)
Number of subjects: 11
Study: 34147554

Group type: EXPERIMENTAL
Intervention: Intermediate-size Myval THVs (21.5, 24.5, 27.5 mm)
Number of subjects: 1115

Group type: EXPERIMENTAL
Intervention: Intermediate-size Myval THVs
Number of subjects: 1115
Study: 33301991

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control (consult with FORCE exercise trainer, online exercise RT training program, resistance bands)
Number of subjects: 180
Study: 33238961

Group type: COMPARATOR
Intervention: saline
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: chitosan
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: propolis 100 µg/ml (P100)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: propolis 250 µg/ml (P250)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: chitosan-propolis nanoparticle 100 µg/ml (CPN100)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: chitosan-propolis nanoparticle 250 µg/ml (CPN250)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: calcium hydroxide (CH)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX) gel
Number of subjects: 240
Study: 33658655

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 35426733

Group type: EXPERIMENTAL
Intervention: Yoga program (75-min classes, twice weekly for 4 weeks, then once a week for 8 weeks, total 16 classes)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Educational film program (75-min classes, once weekly for 12 weeks, total 12 classes)
Number of subjects: 41
Study: 32565388

Group type: COMPARATOR
Intervention: Chemotherapy (control group)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus Denosumab (120 mg every 3–4 weeks)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Patients with bone metastasis (subgroup analysis)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Patients without bone metastasis (subgroup analysis)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Adverse events grade 3 or greater
Number of subjects: 514
Study: 36180619

Group type: EXPERIMENTAL
Intervention: Perioperative oral immunonutrition
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard nutritional feeds
Number of subjects: 62
Study: 34422262

Group type: EXPERIMENTAL
Intervention: 40 g sucrose in 500 ml water
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 80 g sucrose in 500 ml water
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 120 g sucrose in 500 ml water
Number of subjects: 12
Study: 34087804

Group type: EXPERIMENTAL
Intervention: Intrathecal nicardipine
Number of subjects: 1351

Group type: COMPARATOR
Intervention: Control group (no IT nicardipine)
Number of subjects: 1351
Study: 33132093

Group type: EXPERIMENTAL
Intervention: Direct Anterior Approach (DAA)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Posterior Approach (PA)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both approaches (DAA and PA)
Number of subjects: 55
Study: 35675902

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia alone (MACSEVO)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia with morphine (10 mg/kg) (MACSEVO+MOR)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no morphine)
Number of subjects: 6
Study: 33687321

Group type: EXPERIMENTAL
Intervention: Telemedicine evaluation via audio-video conferencing
Number of subjects: 90

Group type: COMPARATOR
Intervention: In-person evaluation by a clinician investigator
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Telemedicine evaluation
Number of subjects: 90

Group type: COMPARATOR
Intervention: In-person evaluation
Number of subjects: 90
Study: 32100031

Group type: EXPERIMENTAL
Intervention: Oral antibiotics given to children
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Antibiotic use among children
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Average number of antibiotic courses per child
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Antibiotics given without a prescription
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Parental knowledge of antibiotic indications
Number of subjects: 2157
Study: 34078487

Group type: EXPERIMENTAL
Intervention: Nutrition Module promoting the Mediterranean Diet (MedDiet)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition Module
Number of subjects: 0
Study: 34847112

Group type: EXPERIMENTAL
Intervention: Rhinogoniometer measurement
Number of subjects: 31
Study: 35383339

Group type: EXPERIMENTAL
Intervention: 5 mg/day folate supplements
Number of subjects: 60
Study: 33655789

Group type: EXPERIMENTAL
Intervention: RETRAINER + ACT
Number of subjects: 72

Group type: COMPARATOR
Intervention: ACT
Number of subjects: 72
Study: 32817266

Group type: EXPERIMENTAL
Intervention: Telehealth home monitoring program (REACH) layered on usual care
Number of subjects: 219
Study: 35435877

Group type: EXPERIMENTAL
Intervention: Mindfulness-based breathing and music therapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 104
Study: 34328141

Group type: EXPERIMENTAL
Intervention: MYNd&CO intervention plus standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 32932009

Group type: EXPERIMENTAL
Intervention: Henna applied topically (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatment and care (Control group, n=30)
Number of subjects: 60
Study: 34545530

Group type: EXPERIMENTAL
Intervention: Intercostal Cryo Nerve Block (CryoNB)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 84
Study: 32162351

Group type: EXPERIMENTAL
Intervention: Therapeutic activity kit in addition to usual care
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 112
Study: 34247893

Group type: EXPERIMENTAL
Intervention: Laser-cane with 15-min walking training and 15-min traditional physical therapy (EG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional rehabilitation without laser-cane (CG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Laser-cane (EG)
Number of subjects: 30
Study: 33143121

Group type: EXPERIMENTAL
Intervention: Soluble Fiber Dextrin (SFD)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 33049489

Group type: EXPERIMENTAL
Intervention: CISSS scoring system
Number of subjects: 534001
Study: 35222899

Group type: EXPERIMENTAL
Intervention: Multidisciplinary combined nondrug therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional conservative treatment (control group)
Number of subjects: 70
Study: 33524191

Group type: EXPERIMENTAL
Intervention: RT + PCV
Number of subjects: 355

Group type: COMPARATOR
Intervention: RT + TMZ
Number of subjects: 355
Study: 32678772

Group type: EXPERIMENTAL
Intervention: One-wheeled wheelbarrow
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-wheeled wheelbarrow
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grass surface
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asphalt pavement
Number of subjects: 0
Study: 37879803

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 179

Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 179
Study: 32822614

Group type: EXPERIMENTAL
Intervention: Sildenafil (20 mg three times daily) added to pirfenidone (801 mg three times daily)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo added to pirfenidone (801 mg three times daily)
Number of subjects: 177
Study: 32726513

Group type: COMPARATOR
Intervention: norm‐ITL (FIO2 = 21%)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: hyp‐ITL (FIO2 = 15%)
Number of subjects: 13
Study: 35708690

Group type: EXPERIMENTAL
Intervention: Community health promoters intervention
Number of subjects: 1851

Group type: COMPARATOR
Intervention: Outreach as usual wait-listed controls
Number of subjects: 1851
Study: 33557875

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35799106

Group type: EXPERIMENTAL
Intervention: Dual-channel elastomeric pump (Group D)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (Group C) - PCA drugs only in the constant flow chamber with normal saline in the adjustable flow chamber
Number of subjects: 90
Study: 32951121

Group type: EXPERIMENTAL
Intervention: Passiflora incarnata (500 mg)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Erythrina mulungu (500 mg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 35428324

Group type: EXPERIMENTAL
Intervention: Baihu and Guizhi decoction (BHGZ) plus low-dose colchicine
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo plus low-dose colchicine
Number of subjects: 102
Study: 33475705

Group type: EXPERIMENTAL
Intervention: Capecitabine plus Irinotecan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Irinotecan monotherapy
Number of subjects: 0
Study: 32245506

Group type: EXPERIMENTAL
Intervention: Database-screening tools for recruitment
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Short message service (SMS) or email reminders for retention
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Digital tools in general
Number of subjects: 24
Study: 35223519

Group type: EXPERIMENTAL
Intervention: PPA (paravertebral blocks and propofol general anesthesia)
Number of subjects: 1253

Group type: COMPARATOR
Intervention: GA (sevoflurane and opioids general anesthesia)
Number of subjects: 1253
Study: 33039635

Group type: EXPERIMENTAL
Intervention: Early prophylaxis (EP) within ≤48 hours after emergency department arrival
Number of subjects: 146

Group type: COMPARATOR
Intervention: Late prophylaxis (LP) after >48 hours
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Early prophylaxis (EP)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Late prophylaxis (LP)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Timing of pharmacologic VTE prophylaxis initiation
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Pelvic angioembolization
Number of subjects: 146
Study: 35995058

Group type: EXPERIMENTAL
Intervention: Web-based aftercare
Number of subjects: 300

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Face-to-Face (F2F) therapy
Number of subjects: 300
Study: 32084353

Group type: EXPERIMENTAL
Intervention: BBM combined with simvastatin
Number of subjects: 12

Group type: COMPARATOR
Intervention: BBM alone
Number of subjects: 12
Study: 36138055

Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham therapy (placebo needles)
Number of subjects: 40
Study: 35435981

Group type: EXPERIMENTAL
Intervention: Snoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dozing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Right arm fat mass
Number of subjects: 0